This is supported by findings that reported the correlation between severe infections and accelerated cognitive decline in AD, linked to increased levels of peripheral tumor necrosis factor alpha (TNF-α) and the beneficial role of non-steroidal anti-inflammatory drugs in lowering the disease risk. This evidence concerns the gene TNF and Alzheimer disease.